Drug/Small Molecule:
primidone

2D structure

Overview

Trade Names: Apo-Primidone; Cyral; Desoxyphenobarbitone; Hexadiona; Hexamidine; Lepimidin; Lepsiral; Liskantin; Majsolin; Medi-Pets; Midone; Milepsin; Misodine; Misolyne; Mizodin; Mizolin; Myidone; Mylepsin; Mylepsinum; Mysedon; Mysoline; Neurosyn; Pms Primidone; Prilepsin; Primacione; Primaclone; Primacone; Primakton; Primidon; Primidone Methanol Solution; Primoline; Prysoline; Pyrimidone "Medi-Pets"; Pyrimidone Medi-Pets; Resimatil; Sertan
PharmGKB Accession Id: PA451105

Description

An antiepileptic agent related to the barbiturates; it is partly metabolized to phenobarbital in the body and owes some of its actions to this metabolite. Adverse effects are reported to be more frequent than with phenobarbital. (From Martindale, The Extra Pharmacopoeia, 30th ed, p309) (source: Drug Bank)

Indication

For the treatment of epilepsy (source: Drug Bank)

ATC Therapeutic Category

  • N03AA:Barbiturates and derivatives

Pharmacology, Interactions, and Contraindications

Mechanism Of Action

Primidone is a GABA receptor agonist. The mechanism of Primidone's antiepileptic action is not known. (source: Drug Bank)

Pharmacology

Primidone is a barbiturate with anticonvulsant properties. Primidone, either alone or used concomitantly with other anticonvulsants, is indicated in the control of grand mal, psychomotor, and focal epileptic seizures. It may control grand mal seizures refractory to other anticonvulsant therapy. Primidone raises electro- or chemoshock seizure thresholds or alters seizure patterns in experimental animals. Primidone per se has anticonvulsant activity as do its two metabolites, phenobarbital and phenylethylmalonamide (PEMA). In addition to its anticonvulsant activity, Primidone potentiates that of phenobarbital in experimental animals. (source: Drug Bank)

Food Interactions

Avoid alcohol.
Avoid high doses of caffeine.
Take with food to reduce gastric irritation. (source: Drug Bank)

Absorption, Distribution, Metabolism, Elimination & Toxicity

Biotransformation

Hepatic (source: Drug Bank)

Protein Binding

70% (source: Drug Bank)

Absorption

90 to 100% (source: Drug Bank)

Isomeric SMILES Code:

CCC1(C(=O)NCNC1=O)c2ccccc2 (source: Drug Bank)

A list of non-curated publications that mention this drug along with other genes is available.

Drug Targets

Gene Description
GABRA1 Uncurated Annotation (source: Drug Bank)

A list of non-curated publications that mention this drug along with other drugs is available.

Drug Interactions

Drug Description
acenocoumarol Uncurated Annotation The barbiturate decreases the anticoagulant effect (source: Drug Bank)
clomifene Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
cortisone acetate Uncurated Annotation The barbiturate decreases the effect of the corticosteroid (source: Drug Bank)
cyclosporine Uncurated Annotation The barbiturate increases the effect of cyclosporine (source: Drug Bank)
dexamethasone Uncurated Annotation The barbiturate decreases the effect of the corticosteroid (source: Drug Bank)
dicumarol Uncurated Annotation The barbiturate decreases the anticoagulant effect (source: Drug Bank)
diethylstilbestrol Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
doxycycline Uncurated Annotation The anticonvulsant decreases the effect of doxycycline (source: Drug Bank)
estradiol Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
estrone Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
ethinyl estradiol Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
felbamate Uncurated Annotation Felbamate increases the effect and toxicity of primidone (source: Drug Bank)
felodipine Uncurated Annotation The barbiturate decreases the effect of felodipine (source: Drug Bank)
folic acid Uncurated Annotation Folic acid decreases the effect of anticonvulsant (source: Drug Bank)
gefitinib Uncurated Annotation This CYP3A4 inducer may reduce gefitinib plasma concentrations and pharmacological effects (source: Drug Bank)
griseofulvin Uncurated Annotation The barbiturate decreases the effect of griseofulvine (source: Drug Bank)
hydrocortisone Uncurated Annotation The barbiturate decreases the effect of the corticosteroid (source: Drug Bank)
levonorgestrel Uncurated Annotation Phenobarbital decreases the effect of levonorgestrel (source: Drug Bank)
medroxyprogesterone Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
megestrol Uncurated Annotation The enzyme inducer decreases the effect of hormones (source: Drug Bank)
mestranol Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
methadone Uncurated Annotation The barbiturate decreases the effect of methadone (source: Drug Bank)
methoxyflurane Uncurated Annotation The barbiturate increases the renal toxicity of methoxyflurane (source: Drug Bank)
methylprednisolone Uncurated Annotation The barbiturate decreases the effect of the corticosteroid (source: Drug Bank)
metoprolol Uncurated Annotation The barbiturate decreases the effect of metabolized beta-blocker (source: Drug Bank)
metronidazole Uncurated Annotation The barbiturate decreases the effect of metronidazole (source: Drug Bank)
nifedipine Uncurated Annotation The barbiturate decreases the effect of the calcium channel blocker (source: Drug Bank)
norethindrone Uncurated Annotation This product may cause a slight decrease of contraceptive effect (source: Drug Bank)
prednisolone Uncurated Annotation The barbiturate decreases the effect of the corticosteroid (source: Drug Bank)
prednisone Uncurated Annotation The barbiturate decreases the effect of the corticosteroid (source: Drug Bank)
propranolol Uncurated Annotation The barbiturate decreases the effect of metabolized beta-blocker (source: Drug Bank)
quinidine Uncurated Annotation The anticonvulsant decreases the effect of quinidine (source: Drug Bank)
theophylline Uncurated Annotation The barbiturate decreases the effect of theophylline (source: Drug Bank)
triamcinolone Uncurated Annotation The barbiturate decreases the effect of the corticosteroid (source: Drug Bank)
verapamil Uncurated Annotation The barbiturate decreases the effect of the calcium channel blocker (source: Drug Bank)
voriconazole Uncurated Annotation The barbiturate decreases the effect of voriconazole (source: Drug Bank)
warfarin Uncurated Annotation The barbiturate decreases the anticoagulant effect (source: Drug Bank)

Non-Curated Information

A list of non-curated publications that mention this drug along with other diseases is available.

Additional Datasets

These datasets are minimally curated and are sorted alphabetically by title.

  1. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

LinkOuts

Web Resource:
Wikipedia
DrugBank:
DB00794
KEGG Compound ID:
C07371
KEGG Drug ID:
D00474
PubChem Compound ID:
4909
PubChem Substance ID:
173378

Common Searches

Search PubMed
Search Medline Plus
Search PubChem
Search CTD

Non-Curated Publications

A list of non-curated publications that mention this drug is available.

PharmGKB integrates drug information from different sources: DrugBank, Open Eye Scientific Software.
Add New Alternate Name
Add New ATC Term
Add Cross Reference
Add a metabolite
Add a text annotation
Add a drug target
hint: enter a gene
    Add a drug interaction
    hint: enter a drug
    PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (GM61374).
    ©2001-2010 PharmGKB.